Bayer: leads 65 million dollar investment in genomic firm
(CercleFinance.com) - Bayer has stepped in to lead a 65 million dollar funding round for a California-based generation gene editing company that was launched by UC Berkeley scientists in 2018.
The latest funding will enable Metagenomi to accelerate the expansion of its gene editing systems for potential therapeutic use in oncology and genetic diseases, the German pharmaceutical company said.
The move comes after the Nobel Prize in chemistry this year honored CRISPR, a gene-based editing system that applies computational algorithms to screen thousands of genomes from microorganisms around the world.
Copyright (c) 2020 CercleFinance.com. All rights reserved.